{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "1699801", "DateCompleted": {"Year": "1990", "Month": "12", "Day": "13"}, "DateRevised": {"Year": "2019", "Month": "06", "Day": "20"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0014-5793", "JournalIssue": {"Volume": "272", "Issue": "1-2", "PubDate": {"Year": "1990", "Month": "Oct", "Day": "15"}}, "Title": "FEBS letters", "ISOAbbreviation": "FEBS Lett"}, "ArticleTitle": "MAP 30: a new inhibitor of HIV-1 infection and replication.", "Pagination": {"StartPage": "12", "EndPage": "18", "MedlinePgn": "12-8"}, "Abstract": {"AbstractText": ["A new inhibitor of human immunodeficiency virus (HIV) has been isolated and purified to homogeneity from the seeds and fruits of the Momordica charantia. This compound, MAP 30 (Momordica Anti-HIV Protein), is a basic protein of about 30 kDa. It exhibits dose-dependent inhibition of cell-free HIV-1 infection and replication as measured by: (i) quantitative focal syncytium formation on CEM-ss monolayers; (ii) viral core protein p24 expression; and (iii) viral-associated reverse transcriptase (RT) activity in HIV-1 infected H9 cells. The doses required for 50% inhibition (ID50) in these assays were 0.83, 0.22 and 0.33 nM, respectively. No cytotoxic or cytostatic effects were found under the assay conditions. These data suggest that MAP 30 may be a useful therapeutic agent in the treatment of HIV-1 infections. The sequence of the N-terminal 44 amino acids of MAP 30 has been determined."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, New York University School of Medicine, NY 10016."}], "LastName": "Lee-Huang", "ForeName": "S", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Huang", "ForeName": "P L", "Initials": "PL"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Nara", "ForeName": "P L", "Initials": "PL"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Chen", "ForeName": "H C", "Initials": "HC"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Kung", "ForeName": "H F", "Initials": "HF"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Huang", "ForeName": "P", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Huang", "ForeName": "H I", "Initials": "HI"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Huang", "ForeName": "P L", "Initials": "PL"}], "PublicationTypeList": ["Comparative Study", "Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "FEBS Lett", "NlmUniqueID": "0155157", "ISSNLinking": "0014-5793"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Gene Products, gag"}, {"RegistryNumber": "0", "NameOfSubstance": "HIV Core Protein p24"}, {"RegistryNumber": "0", "NameOfSubstance": "MAP30 protein, Momordica charantia"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Reverse Transcriptase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Ribosome Inactivating Proteins, Type 2"}, {"RegistryNumber": "0", "NameOfSubstance": "Viral Core Proteins"}], "MeshHeadingList": [{"QualifierName": ["drug therapy"], "DescriptorName": "Acquired Immunodeficiency Syndrome"}, {"QualifierName": [], "DescriptorName": "Amino Acid Sequence"}, {"QualifierName": ["isolation & purification", "pharmacology", "therapeutic use"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": ["biosynthesis"], "DescriptorName": "Gene Products, gag"}, {"QualifierName": [], "DescriptorName": "HIV Core Protein p24"}, {"QualifierName": ["drug effects", "physiology"], "DescriptorName": "HIV-1"}, {"QualifierName": [], "DescriptorName": "Molecular Sequence Data"}, {"QualifierName": ["isolation & purification", "pharmacology", "therapeutic use"], "DescriptorName": "Plant Proteins"}, {"QualifierName": ["analysis"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Reverse Transcriptase Inhibitors"}, {"QualifierName": [], "DescriptorName": "Ribosome Inactivating Proteins, Type 2"}, {"QualifierName": [], "DescriptorName": "Sequence Homology, Nucleic Acid"}, {"QualifierName": ["microbiology"], "DescriptorName": "T-Lymphocytes"}, {"QualifierName": ["biosynthesis"], "DescriptorName": "Viral Core Proteins"}, {"QualifierName": ["drug effects"], "DescriptorName": "Virus Replication"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1990", "Month": "10", "Day": "15"}, {"Year": "1990", "Month": "10", "Day": "15", "Hour": "0", "Minute": "1"}, {"Year": "1990", "Month": "10", "Day": "15", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["1699801", "10.1016/0014-5793(90)80438-o", "0014-5793(90)80438-O"]}}]}